Page 65 - GTM-2-3
P. 65

Global Translational Medicine                                   Influence of ferroptosis in neurological diseases




             A                                              B


































            Figure  4.  Differentially expressed genes (DEGs) regulated by FerrTFs. (A) Alzheimer’s disease DEGs regulated by ferroptotic transcription factors
            (FerrTFs). (B) Parkinson’s disease DEGs regulated by FerrTFs.

            (Figure 3). Subsequently, we identified statistically relevant   DEGs (Figure  4).  Then, we analyzed the targets of these
            sub-networks or clusters from these PPINs using MCODE   FerrTFs within the cluster-specific hub genes to understand
            v2.0.0 app  in Cytoscape v3.9.1. . The default settings   the role of FerrTFs in regulating functional clusters within
                    [25]
                                       [24]
            of MCODE v2.0.0 app were used for module detection.   AD-  and PD-PPIN. Our analysis revealed that 8 and 6
            The AD-PPIN and PD-PPIN consist of 21 and 17 clusters,   FerrTFs regulate hub genes from the 7 and 4 deregulated
            respectively. Next, we performed functional enrichment   clusters of AD and PD, respectively. Figures 5 and 6 illustrate
            analyses on each module using BiNGO in Cytoscape 3.9.1 to   the hub genes that are regulated by FerrTFs and the function
            determine their functional roles during AD and PD.  of the module to which they belong (Figures S1 and S2).
              Hub genes are the most interconnected genes within   3.3. Devising therapeutic miRNAs and drugs
            a  network.  Thus,  in  the  next  step,  we  calculated  the   targeting FerrTFs
            degree centrality of each cluster using Network Analyzer
            in Cytoscape v3.9.1. [24,27] . The mean degree centrality   Finally,  we were  interested  in identifying therapeutic
            for each cluster was used as the cutoff value to select   miRNAs and drugs targeting FerrTFs. Thus, we retrieved
                                                                                                       [30]
            hubs from the clusters (Figures S1 and S2). We aimed to   miRNA-FerrTF interactions from RegNetwork  and
            decipher the influence of ferroptosis in the progression of   drug-FerrTF interactions from Drug SIGnatures DataBase
            neurodegeneration in both AD and PD. To achieve this, we   (DSigDB). Our analysis revealed 126 miRNAs that could
            initially selected probable markers and drivers of ferroptosis   silence 7 FerrTFs and 681 drugs that might have therapeutic
            from FerrDb . Driver genes are likely to induce ferroptosis,   effects against 8 FerrTFs in the case of AD (Figure  7;
                      [28]
            while marker genes indicate the occurrence of ferroptosis.   Table S3). Similarly, 114 miRNAs could have therapeutic
            We considered 162 probable ferroptotic drivers and markers   roles against 5 FerrTFs, and 633 drugs could dampen the
            for our study. We further sought to decode the influence   effects of 6 FerrTFs during PD (Figure 8; Table S3).
            of ferroptosis in instigating neurodegeneration in AD and   4. Discussion
                            [29]
                                             [30]
            PD. Using TRRUST  and RegNetwork , we identified
            25 FerrTFs among the drivers and markers of ferroptosis.   Ferroptosis is an iron-dependent cell death process that
            Initially, we identified targets of these FerrTFs among the   has recently been implicated in the death of dopaminergic

            Volume 2 Issue 3 (2023)                         6                        https://doi.org/10.36922/gtm.0318
   60   61   62   63   64   65   66   67   68   69   70